R De Stefano, E Frati, F Nargi, L Menza. Show Affiliations »
Abstract
Entities: Chemical Disease Gene Species
Mesh: See more » AdalimumabAgedAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal, Murine-Derived/therapeutic useAntirheumatic Agents/adverse effectsArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/immunologyDrug SubstitutionEtanerceptFemaleHumansImmunoglobulin G/adverse effectsMaleMiddle AgedMultiple Pulmonary Nodules/chemically inducedMultiple Pulmonary Nodules/diagnostic imagingMultiple Pulmonary Nodules/drug therapyReceptors, Tumor Necrosis FactorRheumatoid Nodule/chemically inducedRheumatoid Nodule/diagnostic imagingRheumatoid Nodule/drug therapyRituximabTomography, X-Ray ComputedTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitorsTumor Necrosis Factor-alpha/metabolism
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntibodies, Monoclonal, Murine-DerivedAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaRituximabAdalimumabEtanercept
Year: 2011 PMID: 21906436
Source DB: PubMed Journal: Clin Exp Rheumatol ISSN: 0392-856X Impact factor: 4.473